Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Pulmonary Hypertension, April 2022 Free Subscription Abstracts Retrieve all available abstracts of the following 179 articles: HTML format

Single Articles

1. DENG H, Tian X, Sun H, Liu H, et al
   Calpain-1 mediates vascular remodelling and fibrosis via HIF-1alpha in hypoxia-induced pulmonary hypertension.
   J Cell Mol Med. 2022 Apr 1. doi: 10.1111/jcmm.17295.
   PubMed    
   Abstract available
   
   

2. YEO J, Shin N, Ahn KJ, Seo M, et al
   Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension.
   Clin Hypertens. 2022;28:10.
   PubMed    
   Abstract available
   
   

3. ZHONG XJ, Jiang R, Yang L, Yuan P, et al
   Peak oxygen uptake is a strong prognostic predictor for pulmonary hypertension due to left heart disease.
   BMC Cardiovasc Disord. 2022;22:137.
   PubMed    
   Abstract available
   
   

4. SHAHIN Y, Alabed S, Rehan Quadery S, Lewis RA, et al
   CMR Measures of Left Atrial Volume Index and Right Ventricular Function Have Prognostic Value in Chronic Thromboembolic Pulmonary Hypertension.
   Front Med (Lausanne). 2022;9:840196.
   PubMed    
   Abstract available
   
   

5. HUANG Z, Wang M, Hu F, Liu X, et al
   Long-Term Outcomes After Percutaneous Transluminal Pulmonary Angioplasty in Patients With Takayasu Arteritis and Pulmonary Hypertension.
   Front Immunol. 2022;13:828863.
   PubMed    
   Abstract available
   
   

6. GOO HW, Park SH
   Prediction of pulmonary hypertension using central-to-peripheral pulmonary vascular volume ratio on three-dimensional cardiothoracic CT in patients with congenital heart disease.
   Jpn J Radiol. 2022 Mar 31. pii: 10.1007/s11604-022-01272.
   PubMed    
   Abstract available
   
   

7. WOOD JC
   Pulmonary hypertension in thalassemia: a call to action.
   Blood. 2022;139:1937-1938.
   PubMed    
   
   
   

8. XIONG A, Liu Q, Zhong J, Cao Y, et al
   Increased risk of mortality in systemic sclerosis-associated pulmonary hypertension: a systemic review and meta-analysis.
   Adv Rheumatol. 2022;62:10.
   PubMed    
   Abstract available
   
   

9. LI LX, Wei B, Yang M, Li M, et al
   Efficacy and safety of bosentan in the treatment of persistent pulmonary hypertension of the newborn: a Metaanalysis.
   Zhongguo Dang Dai Er Ke Za Zhi. 2022;24:319-325.
   PubMed    
   Abstract available
   
   

10. HERESI GA, Dean BB, Castillo H, Lee HF, et al
    Identifying Patients with Group 3 Pulmonary Hypertension Associated with COPD or ILD Using an Administrative Claims Database.
    Lung. 2022 Mar 29. pii: 10.1007/s00408-022-00521.
    PubMed    
    Abstract available
    
    

11. QUTRIO BALOCH Z, Abbas SA, Prasad RM, Elamin AM, et al
    Potential Role of Cardiopulmonary Exercise Testing as an Early Screening Tool for Patients With Suspected Pulmonary Hypertension Including Exercise-Induced Pulmonary Hypertension: Results From a Retrospective Analysis.
    Perm J. 2021;25.
    PubMed    
    Abstract available
    
    

12. SOLINC J, Raimbault-Machado J, Dierick F, El Bernoussi L, et al
    Platelet-Derived Growth Factor Receptor Type alpha Activation Drives Pulmonary Vascular Remodeling Via Progenitor Cell Proliferation and Induces Pulmonary Hypertension.
    J Am Heart Assoc. 2022 Mar 29:e023021. doi: 10.1161/JAHA.121.023021.
    PubMed    
    Abstract available
    
    

13. CUETO-ROBLEDO G, Roldan-Valadez E, Graniel-Palafox LE, Garcia-Cesar M, et al
    Chronic thromboembolic pulmonary hypertension (CTEPH): a review of another sequel of severe post-Covid-19 pneumonia.
    Curr Probl Cardiol. 2022 Mar 25:101187. doi: 10.1016/j.cpcardiol.2022.101187.
    PubMed    
    Abstract available
    
    

14. QIN X, Gao A, Hou X, Xu X, et al
    Connexins may play a critical role in cigarette smoke-induced pulmonary hypertension.
    Arch Toxicol. 2022 Mar 27. pii: 10.1007/s00204-022-03274.
    PubMed    
    Abstract available
    
    

15. SRNKOVA P, Brucknerova J, Brucknerova I
    Is inhaled nitric oxide a miraculous molecule? The analysis of nitric oxide use in newborns with persistent pulmonary hypertension of the newborn.
    Bratisl Lek Listy. 2022;123:153-159.
    PubMed    
    Abstract available
    
    

16. BUTT MU, Jabri A, Hamade H, Abdouh AA, et al
    Predicting the Severity and Outcome of Persistent Pulmonary Hypertension of the Newborn Using New Echocardiography Parameters.
    Curr Probl Cardiol. 2022 Mar 24:101181. doi: 10.1016/j.cpcardiol.2022.101181.
    PubMed    
    Abstract available
    
    

17. XU ZY, Zhang HS, Li QQ, Zhang C, et al
    [Impact of composite clinical worsening events on outcome of patients with pulmonary arterial hypertension associated with congenital heart disease].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2022;50:282-288.
    PubMed    
    Abstract available
    
    

18. BENZA RL, Farber HW, Frost AE, Ghofrani HA, et al
    Application of the REVEAL risk score calculator 2.0 in the CHEST study.
    Respir Med. 2022;195:106783.
    PubMed    
    Abstract available
    
    

19. VIZCARRA-VIZCARRA CA, Alcos-Mamani AL
    High Altitude Pulmonary Edema in a Chronic Kidney Disease Patient-Is Peritoneal Dialysis A Risk Factor?
    High Alt Med Biol. 2022;23:96-99.
    PubMed    
    Abstract available
    
    

20. ZEREN M, Demir R, Sinan UY, Mustafaoglu R, et al
    Prevalence of musculoskeletal pain and its impact on quality of life and functional exercise capacity in patients with pulmonary arterial hypertension.
    Respir Med. 2022;193:106759.
    PubMed    
    Abstract available
    
    

21. KHAN A, White RJ, Meyer G, Pulido Zamudio TR, et al
    Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension.
    Respir Med. 2022;193:106744.
    PubMed    
    Abstract available
    
    

22. WEN-TING L, Chang-Wei W, De-Jian B, Wei S, et al
    Arterial partial pressure of oxygen and procalcitonin levels correlate with pulmonary artery systolic pressure in patients with active pulmonary tuberculosis.
    Int J Infect Dis. 2022;117:87-92.
    PubMed    
    Abstract available
    
    

23. WANG M, Su L, Sun J, Cai L, et al
    FGF21 attenuates pulmonary arterial hypertension via downregulation of miR-130, which targets PPARgamma.
    J Cell Mol Med. 2022;26:1034-1049.
    PubMed    
    Abstract available
    
    

24. CHI PL, Cheng CC, Hung CC, Wang MT, et al
    MMP-10 from M1 macrophages promotes pulmonary vascular remodeling and pulmonary arterial hypertension.
    Int J Biol Sci. 2022;18:331-348.
    PubMed    
    Abstract available
    
    

25. XU X, Wang X, Yang GC, Liu Q, et al
    Identification of a novel mutation in the BMPR2 gene in a pulmonary arterial hypertension patient using next-generation sequencing.
    J Clin Lab Anal. 2022;36:e24183.
    PubMed    
    Abstract available
    
    

26. DIMARCO KG, Beasley KM, Shah K, Speros JP, et al
    No effect of patent foramen ovale on acute mountain sickness and pulmonary pressure in normobaric hypoxia.
    Exp Physiol. 2022;107:122-132.
    PubMed    
    Abstract available
    
    

27. CHEN J, Rathinasabapathy A, Luo J, Yang X, et al
    Differential serum lipid distribution in IPAH and CHD-PAH patients.
    Respir Med. 2022;191:106711.
    PubMed    
    Abstract available
    
    

28. ROSENKRANZ S, Channick R, Chin KM, Jenner B, et al
    The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study.
    Eur J Heart Fail. 2022;24:205-214.
    PubMed    
    Abstract available
    
    

29. DYMEK P, Kielbowski K, Sienkiewicz S, Blaszkowski T, et al
    Leiomyosarcoma in adrenal gland.
    Endokrynol Pol. 2021;72:674-675.
    PubMed    
    Abstract available
    
    

30. MEY JT, Rath MC, McLaughlin K, Galang M, et al
    The breath print represents a novel biomarker of malnutrition in pulmonary arterial hypertension: a proof-of-concept study.
    JPEN J Parenter Enteral Nutr. 2021 Oct 11. doi: 10.1002/jpen.2277.
    PubMed    
    Abstract available
    
    

31. GE X, Zhang W, Zhu T, Huang N, et al
    Hypoxia-activated platelets stimulate proliferation and migration of pulmonary arterial smooth muscle cells by phosphatidylserine/LOX-1 signaling-impelled intercellular communication.
    Cell Signal. 2021;87:110149.
    PubMed    
    Abstract available
    
    

32. ZHANG H, He H, Cui Y, Yu S, et al
    Regulatory effects of HIF-1alpha and HO-1 in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells in yak.
    Cell Signal. 2021;87:110140.
    PubMed    
    Abstract available
    
    

33. FUKUDA S, Nabetani M, Goldman RD, Shinomoto T, et al
    Experience of cases with inhaled nitric oxide and therapeutic hypothermia.
    Pediatr Int. 2022;64:e14901.
    PubMed    
    Abstract available
    
    

34. YILDIZ M, Kahraman S, Surgit O, Zencirkiran Agus H, et al
    Acute effects of inhaled iloprost on intracardiac conduction in patients with pulmonary arterial hypertension.
    Herz. 2022;47:158-165.
    PubMed    
    Abstract available
    
    

35. BELLAFRONTE NT, de Queiros Mattoso Ono A, Chiarello PG
    Sarcopenic Obesity in Chronic Kidney Disease: Challenges in Diagnosis Using Different Diagnostic Criteria.
    Med Princ Pract. 2021;30:477-486.
    PubMed    
    Abstract available
    
    

36. AKKUS NI, Rajpal S, Hilbun J, Dwary A, et al
    Troponin Elevation in Sickle Cell Disease.
    Med Princ Pract. 2021;30:437-442.
    PubMed    
    Abstract available
    
    

37. SHARMA K, Mishra A, Singh HN, Parashar D, et al
    High-altitude pulmonary edema is aggravated by risk loci and associated transcription factors in HIF-prolyl hydroxylases.
    Hum Mol Genet. 2021;30:1734-1749.
    PubMed    
    Abstract available
    
    

38. SILVA AF, Sousa-Nunes F, Faria-Costa G, Rodrigues I, et al
    Effects of chronic moderate alcohol consumption on right ventricle and pulmonary remodelling.
    Exp Physiol. 2021;106:1359-1372.
    PubMed    
    Abstract available
    
    

39. NARIAI R, Mafune R, Ide K, Nishimura N, et al
    Pulmonary hypertension caused by vitamin C deficiency in a 2-year-old girl.
    Pediatr Int. 2022;64:e14971.
    PubMed    
    
    
    

40. KABWE JC, Sawada H, Mitani Y, Oshita H, et al
    CRISPR-mediated Bmpr2 point mutation exacerbates late pulmonary vasculopathy and reduces survival in rats with experimental pulmonary hypertension.
    Respir Res. 2022;23:87.
    PubMed    
    Abstract available
    
    

41. IKUBO Y, Sanada TJ, Hosomi K, Park J, et al
    Altered gut microbiota and its association with inflammation in patients with chronic thromboembolic pulmonary hypertension: a single-center observational study in Japan.
    BMC Pulm Med. 2022;22:138.
    PubMed    
    Abstract available
    
    

42. KOIKE H, Sueyoshi E, Uetani M
    Diagnosis of Chronic Thromboembolic Pulmonary Hypertension Using Quantitative Lung Perfusion Parameters Extracted From Dual-energy Computed Tomography Images.
    J Thorac Imaging. 2022 Apr 11. pii: 00005382-990000000-00006.
    PubMed    
    Abstract available
    
    

43. ALICI G, Waberi MM, Mohamud MA, Bashir AM, et al
    Pulmonary hypertension among maintenance hemodialysis patients in Somalia: a hospital-based observational study.
    Egypt Heart J. 2022;74:24.
    PubMed    
    Abstract available
    
    

44. GERTZ RJ, Gerhardt F, Kroger JR, Shahzad R, et al
    Spectral Detector CT-Derived Pulmonary Perfusion Maps and Pulmonary Parenchyma Characteristics for the Semiautomated Classification of Pulmonary Hypertension.
    Front Cardiovasc Med. 2022;9:835732.
    PubMed    
    Abstract available
    
    

45. MUTO Y, Sekine A, Hagiwara E, Komatsu S, et al
    Clinical characteristics of pulmonary hypertension in patients with pleuroparenchymal fibroelastosis.
    Respir Investig. 2022 Apr 3. pii: S2212-5345(22)00021.
    PubMed    
    Abstract available
    
    

46. KANNEY M, Hsu D
    Pulmonary hypertension in children with severe OSA: can CO2 provide a clue?
    J Clin Sleep Med. 2022 Apr 8. doi: 10.5664/jcsm.10034.
    PubMed    
    
    
    

47. ALANDEJANI F, Alabed S, Garg P, Goh ZM, et al
    Training and clinical testing of artificial intelligence derived right atrial cardiovascular magnetic resonance measurements.
    J Cardiovasc Magn Reson. 2022;24:25.
    PubMed    
    Abstract available
    
    

48. RONG W, Liu C, Li X, Wan N, et al
    Caspase-8 Promotes Pulmonary Hypertension by Activating Macrophage-Associated Inflammation and IL-1beta (Interleukin 1beta) Production.
    Arterioscler Thromb Vasc Biol. 2022 Apr 7:101161ATVBAHA121317168.
    PubMed    
    Abstract available
    
    

49. YOUNGER J, Fayed M, Chauhan G, Mantel N, et al
    Intrathecal Fentanyl With a Paracervical Block Is Safe and Effective for Elective Termination of Pregnancy in a Patient With Primary Pulmonary Hypertension.
    Cureus. 2022;14:e22699.
    PubMed    
    Abstract available
    
    

50. GUAN YT, Zhang R, Wang TY, Wei A, et al
    [Chronic active Epstein-Barr virus infection complicated with pulmonary arterial hypertension in a child].
    Zhonghua Er Ke Za Zhi. 2022;60:355-357.
    PubMed    
    
    
    

51. OKADA N, Takiguchi H, Suzuki W, Okazaki E, et al
    ANCA-Associated Vasculitis in a Patient with Chronic Thromboembolic Pulmonary Hypertension.
    Tokai J Exp Clin Med. 2022;47:26-30.
    PubMed    
    Abstract available
    
    

52. AKCABELEN YM, Kaya Dincel G, Ece I, Cinel G, et al
    Idiopathic Hypereosinophilic Syndrome Associated With Pulmonary Hypertension in an Infant.
    J Pediatr Hematol Oncol. 2022 Apr 1. pii: 00043426-990000000-00005.
    PubMed    
    Abstract available
    
    

53. SHARIF-KASHANI B, Serati A, Shafaghi S, Behzadnia N, et al
    Curable Syncope in Primary Pulmonary Hypertension with Novel Atrial Flow Regulator.
    Tanaffos. 2021;20:287-290.
    PubMed    
    Abstract available
    
    

54. WESTHOFF M, Litterst P, Kreppein U
    [Pulmonary Hypertension and Polycythemia vera].
    Pneumologie. 2022 Apr 5. doi: 10.1055/a-1775-6424.
    PubMed    
    Abstract available
    
    

55. ZHANG Y, Wang Y
    Cell-to-Cell Crosstalk: A New Insight into Pulmonary Hypertension.
    Rev Physiol Biochem Pharmacol. 2022 Apr 6. doi: 10.1007/112_2022.
    PubMed    
    Abstract available
    
    

56. LIU S, Zhang Q, Liu W, Zheng L, et al
    Hereditary haemorrhagic telangiectasia with atrial septal defect and pulmonary hypertension during advanced pregnancy: a case report and literature review.
    J Int Med Res. 2022;50:3000605221085427.
    PubMed    
    Abstract available
    
    

57. PEREIRA AR, Cale R, Ferreira F, Pereira H, et al
    Balloon pulmonary angioplasty in inoperable chronic thromboembolic pulmonary hypertension.
    BMJ Case Rep. 2022;15.
    PubMed    
    Abstract available
    
    

58. SAGRIS M, Kokkinidis DG, Bakoyiannis C
    Contemporary Management of Deep Vein Thrombosis, Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension.
    Curr Pharm Des. 2022;28:511.
    PubMed    
    
    
    

59. BOULATE D, Amsallem M, Menager JB, Dang Van S, et al
    Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension.
    J Vis Exp. 2022;.
    PubMed    
    Abstract available
    
    

60. JASTANIA EI, Alqarni MS, Abukhodair AW, Bukhari ZM, et al
    Risk Factors of Persistent Pulmonary Hypertension in Neonate in A Tertiary Care Referral Center.
    Cureus. 2022;14:e22416.
    PubMed    
    Abstract available
    
    

61. CASTILLO-GALAN S, Riquelme B, Iturriaga R
    Crucial Role of Stromal Interaction Molecule-Activated TRPC-ORAI Channels in Vascular Remodeling and Pulmonary Hypertension Induced by Intermittent Hypoxia.
    Front Physiol. 2022;13:841828.
    PubMed    
    Abstract available
    
    

62. CHEN X, He Y, Yu Z, Zuo J, et al
    Polydatin Glycosides Improve Monocrotaline-Induced Pulmonary Hypertension Injury by Inhibiting Endothelial-To-Mesenchymal Transition.
    Front Pharmacol. 2022;13:862017.
    PubMed    
    Abstract available
    
    

63. JING X, Wu S, Liu Y, Wang H, et al
    Circular RNA Sirtuin1 represses pulmonary artery smooth muscle cell proliferation, migration and autophagy to ameliorate pulmonary hypertension via targeting microRNA-145-5p/protein kinase-B3 axis.
    Bioengineered. 2022;13:8759-8771.
    PubMed    
    Abstract available
    
    

64. LEONG K, Howard L, Lo Giudice F, Pavey H, et al
    MRI Feature Tracking Strain in Pulmonary Hypertension: Utility of Combined Left Atrial Volumetric and Deformation Assessment in Distinguishing Post- From Pre-capillary Physiology.
    Front Cardiovasc Med. 2022;9:787656.
    PubMed    
    Abstract available
    
    

65. YANG DP, Dong WP, Yang YC, Zeng YY, et al
    Tetramethylpyrazine Improves Monocrotaline-Induced Pulmonary Hypertension through the ROS/iNOS/PKG-1 Axis.
    J Healthc Eng. 2022;2022:1890892.
    PubMed    
    Abstract available
    
    

66. SU JY, Chen HF, Wang SM
    Pregnancy outcome analysis of 94 patients with pulmonary arterial hypertension during pregnancy.
    Eur Rev Med Pharmacol Sci. 2022;26:1970-1977.
    PubMed    
    Abstract available
    
    

67. GUILLEN-DEL-CASTILLO A, Meseguer ML, Fonollosa-Pla V, Gimenez BS, et al
    Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.
    Sci Rep. 2022;12:5289.
    PubMed    
    Abstract available
    
    

68. EICHSTAEDT CA, Sassmannshausen Z, Shaukat M, Cao D, et al
    Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension.
    Respir Res. 2022;23:74.
    PubMed    
    Abstract available
    
    

69. ZOZAYA N, Abdalla F, Casado Moreno I, Crespo-Diz C, et al
    The economic burden of pulmonary arterial hypertension in Spain.
    BMC Pulm Med. 2022;22:105.
    PubMed    
    Abstract available
    
    

70. YE C, Lian G, Wang T, Chen A, et al
    The zinc transporter ZIP12 regulates monocrotaline-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/ERK signaling pathways.
    BMC Pulm Med. 2022;22:111.
    PubMed    
    Abstract available
    
    

71. KOBAYASHI T, Kim JD, Naito A, Yanagisawa A, et al
    Multiomics analysis of right ventricles in rat models of pulmonary arterial hypertension: Consideration of mitochondrial biogenesis by chrysin.
    Int J Mol Med. 2022;49.
    PubMed    
    Abstract available
    
    

72. TORRES PPTES, Rabahi MF, Mancano AD, Santos SHRD, et al
    Frequency of spontaneous detection of pulmonary arterial thrombi in unenhanced chest computed tomography in patients diagnosed with pulmonary embolism.
    J Bras Pneumol. 2022;48:e20210128.
    PubMed    
    
    
    

73. JANG SY, Kim EK, Huh J, Song J, et al
    A Retrospective Population-Based Survival Study of Idiopathic Pulmonary Arterial Hypertension in Korea.
    J Korean Med Sci. 2022;37:e80.
    PubMed    
    Abstract available
    
    

74. SCHAFER M, Frank BS, Ivy DD, Mitchell MB, et al
    Repolarization Dispersion Is Associated With Diastolic Electromechanical Discoordination in Children With Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2022;11:e024787.
    PubMed    
    Abstract available
    
    

75. WELCH CL, Chung WK
    Channelopathy Genes in Pulmonary Arterial Hypertension.
    Biomolecules. 2022;12.
    PubMed    
    Abstract available
    
    

76. XIANG Y, Zheng F, Zhang Q, Zhang R, et al
    Tanreqing Injection Regulates Cell Function of Hypoxia-Induced Human Pulmonary Artery Smooth Muscle Cells (HPASMCs) through TRPC1/CX3CL1 Signaling Pathway.
    Oxid Med Cell Longev. 2022;2022:3235102.
    PubMed    
    Abstract available
    
    

77. CHANG WT, Wu CC, Lin YW, Shih JY, et al
    Dynamic Changes in miR-21 Regulate Right Ventricular Dysfunction in Congenital Heart Disease-Related Pulmonary Arterial Hypertension.
    Cells. 2022;11.
    PubMed    
    Abstract available
    
    

78. CHOWDHURY UK, Anderson RH, Spicer DE, Sankhyan LK, et al
    A review of the therapeutic management of multiple ventricular septal defects.
    J Card Surg. 2022;37:1361-1376.
    PubMed    
    Abstract available
    
    

79. ALDRED MA
    Food for Thought: The Emerging Role of Intestinal Microbiota in Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2022;66:361-362.
    PubMed    
    
    
    

80. MPRAH R, Ma Y, Adzika GK, Ndzie Noah ML, et al
    Metabotropic glutamate receptor 5 blockade attenuates pathological cardiac remodelling in pulmonary arterial hypertension.
    Clin Exp Pharmacol Physiol. 2022;49:558-566.
    PubMed    
    Abstract available
    
    

81. WU Y, Liu HM, Gu L, Li QW, et al
    Prostacyclins and pulmonary arterial hypertension in children.
    Eur Rev Med Pharmacol Sci. 2022;26:37-45.
    PubMed    
    Abstract available
    
    

82. LOVERING AT, Kelly TS, DiMarco KG, Bradbury KE, et al
    Implications of a patent foramen ovale for environmental physiology and pathophysiology: do we know the 'hole' story?
    J Physiol. 2022;600:1541-1553.
    PubMed    
    Abstract available
    
    

83. PINTO VM, Musallam KM, Derchi G, Graziadei G, et al
    Mortality in beta-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization.
    Blood. 2022;139:2080-2083.
    PubMed    
    
    
    

84. HE W, Su X, Chen L, Liu C, et al
    Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension.
    Physiol Rep. 2022;10:e15101.
    PubMed    
    Abstract available
    
    

85. CONSTANTINE A, Dimopoulos K, Jenkins P, Tulloh RMR, et al
    Use of Pulmonary Arterial Hypertension Therapies in Patients with a Fontan Circulation: Current Practice Across the United Kingdom.
    J Am Heart Assoc. 2022;11:e023035.
    PubMed    
    Abstract available
    
    

86. REHMEL J, Ferguson-Sells L, Morse BL, Li B, et al
    Physiologically based pharmacokinetic modeling of tadalafil to inform pediatric dose selection in children with pulmonary arterial hypertension.
    CPT Pharmacometrics Syst Pharmacol. 2022;11:173-184.
    PubMed    
    Abstract available
    
    

87. HATAI E, Muneuchi J, Sugitani Y, Doi H, et al
    Pulmonary vascular resistance and compliance in individuals with trisomy 18.
    Am J Med Genet A. 2022;188:534-539.
    PubMed    
    Abstract available
    
    

88. FURUKAWA A, Tamura Y, Yamada K, Taniguchi H, et al
    Liver fibrosis index as a novel prognostic factor in patients with pulmonary arterial hypertension.
    Heart Vessels. 2022;37:601-608.
    PubMed    
    Abstract available
    
    

89. MINHAS J, Shou H, Hershman S, Zamanian R, et al
    Physical Activity and Its Association with Traditional Outcome Measures in Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2022;19:572-582.
    PubMed    
    Abstract available
    
    

90. SEDHOM R, Megaly M, Gupta E, Amanullah A, et al
    Use of direct oral anticoagulants in chronic thromboembolic pulmonary hypertension: a systematic review.
    J Thromb Thrombolysis. 2022;53:51-57.
    PubMed    
    Abstract available
    
    

91. ROBLEDO GC, Palafox LEG, Hernandez MYJ, Paez YAC, et al
    Tricuspid Atresia with Persistent Left Superior Vena Cava and Pulmonary Arterial Hypertension. Case Report.
    Curr Probl Cardiol. 2022;47:100837.
    PubMed    
    
    
    

92. RICHTER MJ, Yogeswaran A, Husain-Syed F, Vadasz I, et al
    A novel non-invasive and echocardiography-derived method for quantification of right ventricular pressure-volume loops.
    Eur Heart J Cardiovasc Imaging. 2022;23:498-507.
    PubMed    
    Abstract available
    
    

93. ROGULA SP, Mutwil HM, Gasecka A, Kurzyna M, et al
    Antiplatelet effects of prostacyclin analogues: Which one to choose in case of thrombosis or bleeding?
    Cardiol J. 2021;28:954-961.
    PubMed    
    Abstract available
    
    

94. SUN W, Ota H, Sato H, Yamamoto S, et al
    Systemic-pulmonary collateral supply associated with clinical severity of chronic thromboembolic pulmonary hypertension: a study using intra-aortic computed tomography angiography.
    Eur Radiol. 2022 Apr 14. pii: 10.1007/s00330-022-08768.
    PubMed    
    Abstract available
    
    

95. KASSA B, Lee MH, Kumar R, Mickael C, et al
    Experimental Schistosoma japonicum-induced pulmonary hypertension.
    PLoS Negl Trop Dis. 2022;16:e0010343.
    PubMed    
    Abstract available
    
    

96. HE T, Zhang J, Qiao T, Zhang Z, et al
    Compensatory roles of Protein Related to DAN and Cerberus (PRDC) decrease in pulmonary arterial hypertension.
    Int J Biol Sci. 2022;18:2372-2391.
    PubMed    
    Abstract available
    
    

97. TANG Y, Tan S, Li M, Tang Y, et al
    Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
    BMC Pulm Med. 2022;22:142.
    PubMed    
    Abstract available
    
    

98. RUOPP NF, Cockrill BA
    Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.
    JAMA. 2022;327:1379-1391.
    PubMed    
    Abstract available
    
    

99. BAHADORAN S, Teymouri Y, Hassanpour H, Mohebbi A, et al
    Effect of sage (Salvia officinalis L.) extract in antioxidant status and intestinal morphology of pulmonary hypertensive chickens.
    Vet Med Sci. 2022 Apr 11. doi: 10.1002.
    PubMed    
    Abstract available
    
    

100. PARAJULI N, Kosanovic D
     Editorial: Oxidative Stress in Cardiovascular Diseases and Pulmonary Hypertension.
     Front Cardiovasc Med. 2022;9:868988.
     PubMed    
     
     
     

101. WANG R, Pan J, Han J, Gong M, et al
     Melatonin Attenuates Dasatinib-Aggravated Hypoxic Pulmonary Hypertension via Inhibiting Pulmonary Vascular Remodeling.
     Front Cardiovasc Med. 2022;9:790921.
     PubMed    
     Abstract available
     
     

102. DONG L, Liu X, Wu B, Li C, et al
     Mxi1-0 Promotes Hypoxic Pulmonary Hypertension Via ERK/c-Myc-dependent Proliferation of Arterial Smooth Muscle Cells.
     Front Genet. 2022;13:810157.
     PubMed    
     Abstract available
     
     

103. AFIFY H, Kong A, Bernal J, Elgendy IY, et al
     Pulmonary Hypertension in Pregnancy: Challenges and Solutions.
     Integr Blood Press Control. 2022;15:33-41.
     PubMed    
     Abstract available
     
     

104. SUZUKI S, Aoki Y, Anezaki H, Wakuda C, et al
     Association Between the Presence of Pulmonary Hypertension Before Cardiovascular Surgery and the Nephroprotective Effect of Carperitide: A Retrospective Cohort Study.
     Cureus. 2022;14:e22891.
     PubMed    
     Abstract available
     
     

105. HUANG Y, Su D, Ye B, Huang Y, et al
     Expression and clinical significance of circular RNA hsa_circ_0003416 in pediatric pulmonary arterial hypertension associated with congenital heart disease.
     J Clin Lab Anal. 2022;36:e24273.
     PubMed    
     Abstract available
     
     

106. PREDESCU DN, Mokhlesi B, Predescu SA
     The Impact of Sex Chromosomes in the Sexual Dimorphism of Pulmonary Arterial Hypertension.
     Am J Pathol. 2022;192:582-594.
     PubMed    
     Abstract available
     
     

107. WENCHENG H, Zhang W, An Y, Huang L, et al
     Impact of Pulmonary Arterial Hypertension on Systemic Inflammation, Cardiac Injury and Hemodynamics in Sepsis: A retrospective study from MIMIC-III.
     Am J Med Sci. 2022 Jan 14. pii: S0002-9629(22)00005.
     PubMed    
     Abstract available
     
     

108. AGGARWAL M, Li M, Bhardwaj A, Wallace WD, et al
     Predictors of survival in portopulmonary hypertension: a 20-year experience.
     Eur J Gastroenterol Hepatol. 2022;34:449-456.
     PubMed    
     Abstract available
     
     

109. HIRJI SA, Vinholo TF, Rinewalt DE
     Commentary: Measurement of Right Heart Hemodynamics After Pulmonary Hromboendarterectomy-A Step in the Right Direction.
     Semin Thorac Cardiovasc Surg. 2022;34:90-91.
     PubMed    
     
     
     

110. CAIN MT, Joyce D, Lahr BD, Day CN, et al
     Do Right Heart Hemodynamic Improvements Persist After Pulmonary Thromboendarterectomy?
     Semin Thorac Cardiovasc Surg. 2022;34:80-89.
     PubMed    
     Abstract available
     
     

111. MILLER RJH, Hedman K, Amsallem M, Tulu Z, et al
     Donor and Recipient Size Matching in Heart Transplantation With Predicted Heart and Lean Body Mass.
     Semin Thorac Cardiovasc Surg. 2022;34:158-167.
     PubMed    
     Abstract available
     
     

112. COCHIUS-DEN OTTER S, de Hoog M, Koch BCP, de Winter BCM, et al
     RE: Efficacy and safety of IV sildenafil in the treatment of newborn infants with or at risk of persistent pulmonary hypertension of the newborn.
     J Pediatr. 2022 Apr 18. pii: S0022-3476(22)00333.
     PubMed    
     
     
     

113. GOKNAR N, Kelesoglu E, Kasap N, Uckardes D, et al
     A case of chronic kidney disease with pulmonary hypertension, hyperuricemia, immunodeficiency and other extrarenal findings: Answers.
     Pediatr Nephrol. 2022 Apr 20. pii: 10.1007/s00467-022-05560.
     PubMed    
     
     
     

114. GOKNAR N, Kelesoglu E, Kasap N, Uckardes D, et al
     A case of chronic kidney disease with pulmonary hypertension, hyperuricemia, immunodeficiency and other extrarenal findings: Questions.
     Pediatr Nephrol. 2022 Apr 20. pii: 10.1007/s00467-022-05548.
     PubMed    
     
     
     

115. LODHI SH, Nandavaram S, Malyala R, Anstead M, et al
     Double Lung Transplantation Bridged With Direct Central Ambulatory Veno-Arterial Extracorporeal Membrane Oxygenation in a Pulmonary Hypertension Patient With Extreme Mediastinal Shift.
     Cureus. 2022;14:e23070.
     PubMed    
     Abstract available
     
     

116. KUMARI N, Mallick RK, Suchi S, Sahu RS, et al
     Prevalence of Pulmonary Hypertension in Chronic Kidney Disease.
     J Assoc Physicians India. 2022;70:11-12.
     PubMed    
     Abstract available
     
     

117. CHINTALAPATI A, Babu S, Cs C
     Study of Pulmonary Function Tests in Diabetic Nephropathy.
     J Assoc Physicians India. 2022;70:11-12.
     PubMed    
     Abstract available
     
     

118. MICHALSKI TA, Pszczola J, Lisowska A, Knapp M, et al
     ECG in the clinical and prognostic evaluation of patients with pulmonary arterial hypertension: an underestimated value.
     Ther Adv Respir Dis. 2022;16:17534666221087846.
     PubMed    
     Abstract available
     
     

119. HEIDARI A, Elkhodary KI, Pop C, Badran M, et al
     Patient-specific finite element analysis of heart failure and the impact of surgical intervention in pulmonary hypertension secondary to mitral valve disease.
     Med Biol Eng Comput. 2022 Apr 20. pii: 10.1007/s11517-022-02556.
     PubMed    
     Abstract available
     
     

120. WANG G, Wen B, Deng Z, Zhang Y, et al
     Endothelial progenitor cells stimulate neonatal lung angiogenesis through FOXF1-mediated activation of BMP9/ACVRL1 signaling.
     Nat Commun. 2022;13:2080.
     PubMed    
     Abstract available
     
     

121. LI X, Zhang Y, Su L, Cai L, et al
     FGF21 alleviates pulmonary hypertension by inhibiting mTORC1/EIF4EBP1 pathway via H19.
     J Cell Mol Med. 2022 Apr 19. doi: 10.1111/jcmm.17318.
     PubMed    
     Abstract available
     
     

122. HEATH-FREUDENTHAL A, Toledo-Jaldin L, von Alvensleben I, Lazo-Vega L, et al
     Vascular Disorders of Pregnancy Increase Susceptibility to Neonatal Pulmonary Hypertension in High-Altitude Populations.
     Hypertension. 2022 Apr 19:101161HYPERTENSIONAHA12219078.
     PubMed    
     Abstract available
     
     

123. JANO E, Vaz MJ, Mally PV, Wachtel E, et al
     Pilot study investigating brain natriuretic peptide, troponin, galectin-3 and miRNA-126a-5p as biomarkers of persistent pulmonary hypertension in neonates with hypoxic-ischemic injury receiving therapeutic hypothermia.
     Am J Perinatol. 2022 Apr 18. doi: 10.1055/a-1827-7518.
     PubMed    
     Abstract available
     
     

124. YANG Y, Xu J, Zhou J, Xue J, et al
     High Betaine and Dynamic Increase of Betaine Levels Are Both Associated With Poor Prognosis of Patients With Pulmonary Hypertension.
     Front Cardiovasc Med. 2022;9:852009.
     PubMed    
     Abstract available
     
     

125. ESPINOLA-ZAVALETA N, Antonio-Villa NE, Guerra EC, Nanda NC, et al
     Right Heart Chambers Longitudinal Strain Provides Enhanced Diagnosis and Categorization in Patients With Pulmonary Hypertension.
     Front Cardiovasc Med. 2022;9:841776.
     PubMed    
     Abstract available
     
     

126. RIETH AJ, Grun D, Zarogiannis G, Kriechbaum SD, et al
     Prognostic Power of Pulmonary Arterial Compliance Is Boosted by a Hemodynamic Unloading Test With Glyceryl Trinitrate in Heart Failure Patients With Post-capillary Pulmonary Hypertension.
     Front Cardiovasc Med. 2022;9:838898.
     PubMed    
     Abstract available
     
     

127. DAI HL, Wang D, Guang XF, Zhang WH, et al
     Pulmonary Hypertension in a Patient With Kartagener's Syndrome and a Novel Homozygous Nonsense Mutation in CCDC40 Gene: A Case Report.
     Front Med (Lausanne). 2022;9:860684.
     PubMed    
     Abstract available
     
     

128. LOPEZ-GUDE MJ, Blanco I, Benito-Arnaiz V, Castella M, et al
     Pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension: the Spanish experience.
     Ann Cardiothorac Surg. 2022;11:151-160.
     PubMed    
     Abstract available
     
     

129. VERBELEN T, Godinas L, Maleux G, Coolen J, et al
     Chronic thromboembolic pulmonary hypertension: diagnosis, operability assessment and patient selection for pulmonary endarterectomy.
     Ann Cardiothorac Surg. 2022;11:82-97.
     PubMed    
     Abstract available
     
     

130. GODINAS L, Verbelen T, Delcroix M
     Residual pulmonary hypertension after pulmonary thromboendarterectomy: incidence, pathogenesis and therapeutic options.
     Ann Cardiothorac Surg. 2022;11:163-165.
     PubMed    
     
     
     

131. JAMIESON S, Pomar J
     Surgical treatment for chronic thromboembolic pulmonary hypertension: an historical perspective.
     Ann Cardiothorac Surg. 2022;11:98-105.
     PubMed    
     Abstract available
     
     

132. DE PERROT M, McRae K, Donahoe L, Abdelnour-Berchtold E, et al
     Pulmonary endarterectomy in severe chronic thromboembolic pulmonary hypertension: the Toronto experience.
     Ann Cardiothorac Surg. 2022;11:133-142.
     PubMed    
     Abstract available
     
     

133. BROOKES JDL, Li C, Chung STW, Brookes EM, et al
     Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension: a systematic review.
     Ann Cardiothorac Surg. 2022;11:68-81.
     PubMed    
     Abstract available
     
     

134. FACCIOLI E, Dell'Amore A
     End-stage chronic thromboembolic pulmonary hypertension: is there still room for lung transplantation?-the past, the present and the future.
     Ann Cardiothorac Surg. 2022;11:161-162.
     PubMed    
     
     
     

135. SIMONNEAU G, Dorfmuller P, Guignabert C, Mercier O, et al
     Chronic thromboembolic pulmonary hypertension: the magic of pathophysiology.
     Ann Cardiothorac Surg. 2022;11:106-119.
     PubMed    
     Abstract available
     
     

136. MARTIN-SUAREZ S, Loforte A, Cavalli GG, Gliozzi G, et al
     Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team.
     Ann Cardiothorac Surg. 2022;11:120-127.
     PubMed    
     Abstract available
     
     

137. QAMAR F, Attar RH, Nabi F
     Paravalvular Leak.
     Methodist Debakey Cardiovasc J. 2022;18:7-9.
     PubMed    
     Abstract available
     
     

138. ADACHI S, Nakano Y, Furusawa K
     Right Ventricular Dyssynchrony Casts New Light on the Risk Stratification and Prediction of Prognosis in Patients With Pulmonary Hypertension.
     Circ J. 2022 Apr 16. doi: 10.1253/circj.CJ-22-0145.
     PubMed    
     
     
     

139. FANG X, Xie M, Liu X, He Y, et al
     REDD1 gene knockout alleviates vascular smooth muscle cell remodeling in pulmonary hypertension.
     Am J Transl Res. 2022;14:1578-1591.
     PubMed    
     Abstract available
     
     

140. ROSCOE AJ, Hwang NC
     Pulmonary thromboendarterectomy and pulmonary haemorrhage.
     Ann Card Anaesth. 2022;25:200-201.
     PubMed    
     Abstract available
     
     

141. COOL CJ, Fathini F, Adams I, Saboe A, et al
     Eisenmenger syndrome with left main compression syndrome: a case report.
     BMC Cardiovasc Disord. 2022;22:89.
     PubMed    
     Abstract available
     
     

142. MARON BA, Humbert M
     Finding Pulmonary Arterial Hypertension-Switching to Offense to Mitigate Disease Burden.
     JAMA Cardiol. 2022;7:369-370.
     PubMed    
     
     
     

143. ZHU Y, Shu D, Gong X, Lu M, et al
     Platelet-Derived TGF (Transforming Growth Factor)-beta1 Enhances the Aerobic Glycolysis of Pulmonary Arterial Smooth Muscle Cells by PKM2 (Pyruvate Kinase Muscle Isoform 2) Upregulation.
     Hypertension. 2022;79:932-945.
     PubMed    
     Abstract available
     
     

144. TAKEMORI W, Yamamura K, Tomita Y, Egami N, et al
     Pediatric pulmonary veno-occlusive disease associated with a novel BMPR2 variant.
     Pediatr Pulmonol. 2022;57:1366-1369.
     PubMed    
     Abstract available
     
     

145. HIGANO NS, Bates AJ, Gunatilaka CC, Hysinger EB, et al
     Bronchopulmonary dysplasia from chest radiographs to magnetic resonance imaging and computed tomography: adding value.
     Pediatr Radiol. 2022 Feb 5. pii: 10.1007/s00247-021-05250.
     PubMed    
     Abstract available
     
     

146. ZAROGOULIDIS P, Petridis D, Sardeli C, Kosmidis C, et al
     Modification Tadalafil and Macitentan tablets to aerosol.
     Front Biosci (Landmark Ed). 2022;27:19.
     PubMed    
     Abstract available
     
     

147. KIM D, Chang D, Kim G
     Congenital portosystemic shunt concurrent with an atrial septal defect in a Maltese dog.
     Open Vet J. 2021;11:724-727.
     PubMed    
     Abstract available
     
     

148. NAKANO Y, Adachi S, Nishiyama I, Yasuda K, et al
     Usefulness of a refined computed tomography imaging method to assess the prevalence of residual pulmonary thrombi in patients 1 year after acute pulmonary embolism: The Nagoya PE study.
     J Thromb Haemost. 2022;20:888-898.
     PubMed    
     Abstract available
     
     

149. ANDERSON JH, Cabalka AK, Frantz RP, Cajigas HR, et al
     Transcatheter Nonductal Reverse Potts Shunt Creation in Pulmonary Arterial Hypertension.
     Circ Cardiovasc Interv. 2021 Dec 21:CIRCINTERVENTIONS121011315.
     PubMed    
     
     
     

150. ISSAPOUR A, Frank B, Crook S, Hite MD, et al
     Safety and tolerability of combination therapy with ambrisentan and tadalafil for the treatment of pulmonary arterial hypertension in children: Real-world experience.
     Pediatr Pulmonol. 2022;57:724-733.
     PubMed    
     Abstract available
     
     

151. WANG Z, Li J, Wang X, Liu M, et al
     Evaluation of pulmonary arterial pressure in patients with connective tissue disease-associated pulmonary arterial hypertension by myocardial perfusion imaging.
     Ann Noninvasive Electrocardiol. 2022;27:e12927.
     PubMed    
     Abstract available
     
     

152. FANG H, Zhang M, Zhao C, Yao X, et al
     Characteristics of length of stay and cardiovascular pharmacotherapy advice among chronic obstructive pulmonary disease patients.
     Sci Prog. 2021;104:368504211066003.
     PubMed    
     Abstract available
     
     

153. HALAWA S, Pullamsetti SS, Bangham CRM, Stenmark KR, et al
     Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective.
     Nat Rev Cardiol. 2022;19:314-331.
     PubMed    
     Abstract available
     
     

154. SCHRANZ D, Schrewe R, Esmaeili A
     Life-threatening PPHN refractory to NO: therapeutic algorithm.
     Eur J Pediatr. 2022;181:423.
     PubMed    
     
     
     

155. FORTAS F, Di Nardo M, Yousef N, Humbert M, et al
     Response to: Life-threatening PPHN refractory to NO: therapeutic algorithm.
     Eur J Pediatr. 2022;181:425-426.
     PubMed    
     
     
     

156. MINHAS J, Baird G, Appleby D, McClelland R, et al
     Terminal Digit Preference in Pulmonary Hypertension Endpoints.
     Am J Respir Crit Care Med. 2022 Apr 5. doi: 10.1164/rccm.202108-2015.
     PubMed    
     
     
     

157. VIZZA CD, Lang IM, Badagliacca R, Benza RL, et al
     Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
     Am J Respir Crit Care Med. 2022;205:751-760.
     PubMed    
     Abstract available
     
     

158. TELLO K, Kremer N, Richter MJ, Gall H, et al
     Inhaled Iloprost Improves Right Ventricular Load-Independent Contractility in Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2022 Apr 15. doi: 10.1164/rccm.202201-0095.
     PubMed    
     
     
     

159. EVRARD B, Goudelin M, Vaidie J, Fedou AL, et al
     Severe Acute Cor Pulmonale in COVID-19 ARDS Patients: Caution with Left Turn.
     Am J Respir Crit Care Med. 2022 Feb 4. doi: 10.1164/rccm.202107-1568.
     PubMed    
     
     
     

160. LIANG M, Yao J, Wang Z, Wu Z, et al
     Endarterectomy for Pulmonary Embolism in a Woman with Unilateral Absence of Pulmonary Artery.
     Ann Thorac Surg. 2021 May 25. pii: S0003-4975(21)00894.
     PubMed    
     Abstract available
     
     

161. KHIRFAN G, Melillo CA, Al Abdi S, Lane JE, et al
     Impact of Esophageal Pressure Measurement on Pulmonary Hypertension Diagnosis in Obese Patients.
     Chest. 2022 Apr 8. pii: S0012-3692(22)00592-X. doi: 10.1016/j.chest.2022.
     PubMed    
     Abstract available
     
     

162. CONDON DF, Agarwal S, Chakraborty A, Auer N, et al
     Novel Mechanisms Targeted by Drug Trials in Pulmonary Arterial Hypertension.
     Chest. 2022;161:1060-1072.
     PubMed    
     Abstract available
     
     

163. VANDERPOOL RR, Hunter KS, Insel M, Garcia JGN, et al
     The Right Ventricular-Pulmonary Arterial Coupling and Diastolic Function Response to Therapy in Pulmonary Arterial Hypertension.
     Chest. 2022;161:1048-1059.
     PubMed    
     Abstract available
     
     

164. STEWART RH, Cox CS Jr, Allen SJ, Laine GA, et al
     Myocardial Edema Provides a Link Between Pulmonary Arterial Hypertension and Pericardial Effusion.
     Circulation. 2022;145:793-795.
     PubMed    
     
     
     

165. RAZA F, Dharmavaram N, Hess T, Dhingra R, et al
     Distinguishing exercise intolerance in early-stage pulmonary hypertension with invasive exercise hemodynamics: Rest VE /VCO2 and ETCO2 identify pulmonary vascular disease.
     Clin Cardiol. 2022 Apr 14. doi: 10.1002/clc.23831.
     PubMed    
     Abstract available
     
     

166. TOSHNER M, Church C, Harbaum L, Rhodes C, et al
     Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension.
     Eur Respir J. 2022;59.
     PubMed    
     Abstract available
     
     

167. ARVANITAKI A, Gatzoulis MA, Opotowsky AR, Khairy P, et al
     Eisenmenger Syndrome: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:1183-1198.
     PubMed    
     Abstract available
     
     

168. OLIN JW, Johnston-Cox H
     Angioplasty to Treat Pulmonary Hypertension in Takayasu Arteritis: An Uncommon Treatment for an Uncommon Disease.
     J Am Coll Cardiol. 2022;79:1489-1491.
     PubMed    
     
     
     

169. ZHOU YP, Wei YP, Yang YJ, Xu XQ, et al
     Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension.
     J Am Coll Cardiol. 2022;79:1477-1488.
     PubMed    
     Abstract available
     
     

170. HENKE VG
     Inhaled Selective Pulmonary Vasodilator Use After Cardiac Surgery: Broader Insights From a Study Describing Significant Changes in Drug Utilization and Savings After Implementation of a Guideline Favoring Inhaled Epoprostenol.
     J Cardiothorac Vasc Anesth. 2022 Jan 23. pii: S1053-0770(22)00055.
     PubMed    
     
     
     

171. BENZA RL, Boucly A, Farber HW, Frost AE, et al
     Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study.
     J Heart Lung Transplant. 2022;41:411-420.
     PubMed    
     Abstract available
     
     

172. VAN WEZENBEEK J, Groeneveldt JA, Llucia-Valldeperas A, van der Bruggen CE, et al
     Interplay of sex hormones and long-term right ventricular adaptation in a Dutch PAH-cohort.
     J Heart Lung Transplant. 2022;41:445-457.
     PubMed    
     Abstract available
     
     

173. SALLMON H, Koestenberger M, Avian A, Reiterer F, et al
     Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension.
     J Perinatol. 2022 Apr 1. pii: 10.1038/s41372-022-01374.
     PubMed    
     Abstract available
     
     

174. DILLARD J, Pavlek LR, Korada S, Chen B, et al
     Worsened short-term clinical outcomes in a cohort of patients with iNO-unresponsive PPHN: a case for improving iNO responsiveness.
     J Perinatol. 2022;42:37-44.
     PubMed    
     Abstract available
     
     

175. DE PERROT M, Donahoe L, McRae K, Thenganatt J, et al
     Outcome after pulmonary endarterectomy for segmental chronic thromboembolic pulmonary hypertension.
     J Thorac Cardiovasc Surg. 2022 Mar 1. pii: S0022-5223(22)00205.
     PubMed    
     Abstract available
     
     

176. CHARLES EJ, Wertheim BM
     Commentary: Small packages, big questions: Mitochondrial transplantation in a preclinical model of pulmonary arterial hypertension.
     J Thorac Cardiovasc Surg. 2022;163:e379-e380.
     PubMed    
     
     
     

177. HSU CH, Roan JN, Fang SY, Chiu MH, et al
     Transplantation of viable mitochondria improves right ventricular performance and pulmonary artery remodeling in rats with pulmonary arterial hypertension.
     J Thorac Cardiovasc Surg. 2022;163:e361-e373.
     PubMed    
     Abstract available
     
     

178. BOLOURANI S, Sari E, Brenner M, Wang P, et al
     The role of eCIRP in bleomycin-induced pulmonary fibrosis in mice.
     PLoS One. 2022;17:e0266163.
     PubMed    
     Abstract available
     
     

179. HAYASHI R, Kogiso T, Kikuchi N, Yamamoto K, et al
     Portopulmonary hypertension and the risk of high right ventricular systolic pressure in liver transplant candidates.
     PLoS One. 2022;17:e0267125.
     PubMed    
     Abstract available